Anticancer Therapies – News and Features

The findings indicate that miRNAs may represent a new class of diagnostic and prognostic tools for lung cancer.

These results concern the identification on 323 patient samples.

Patients are surviving twice as long with DCVax®-Brain as with other therapeutics.

Gene-based drug targeting platform technology, has been shown to be effective in stopping tumour development.

Patent covers any therapeutic gene in combination with radiation and chemotherapy.

UCLA team has developed a testing method to assess the safety and health risks of engineered nanomaterials.

This is thought to be a crucial step forward for researchers who are developing drugs to combat cancer and other diseases.

Nanotrope has been awarded this grant to Advance Nanoscale Drug Delivery.

The study published in the journal Molecular Cell focuses on the ends of DNA, which are capped by segments called telomeres.

Sareum will provide UCB with access to its Crystal Bank protein structures that are drug discovery targets in several therapeutic areas.